Scout | NOT-CA-24-016: Notice of Special Interest (NOSI): Exploratory Cancer Immunology Projects and Technologies (ExCITe)

This opportunity is no longer accepting applications.

grant NOT-CA-24-016

Notice of Special Interest (NOSI): Exploratory Cancer Immunology Projects and Technologies (ExCITe)

Summary

The National Cancer Institute (NCI) is inviting applications for R21 grants aimed at high-risk, high-reward research in cancer immunology. The goal is to explore new ideas or technologies that could enhance our understanding of immune responses, tumor-immune interactions, and immune networks related to cancer. These projects should be innovative and different from typical R01 projects, with th…

The National Cancer Institute (NCI) is encouraging R21 applications for innovative high-risk/high-reward research projects in cancer immunology. The focus is on novel hypotheses or technologies to advance understanding of cancer immunology, including immune responses, tumor-immune ecosystems, an…

Funding Source

Agency: National Institutes of Health

Sub-agency: National Cancer Institute

Eligibility

Higher Education Institutions — Private Institutions of Higher Education

Nonprofit Organizations without 501(c)(3) status (other than Institutions of Higher Education)

Small Businesses

Independent School Districts

Public Housing Authorities/Indian Housing Authorities

Native American Tribal Organizations (other than Federally recognized Tribal Governments)

U.S. Territories or Possessions

Eligible Agencies of the Federal Government

Regional Organizations

Faith-based Organizations

Non-domestic (non-U.S.) components of U.S. Organizations — as allowed by the parent NOFOs

Community-based Organizations

Foreign/Non-domestic Entities (Foreign Institutions) — as allowed by the parent NOFOs (PA-20-195, PA-20-196)

Foreign components of U.S. projects — as allowed by the parent NOFOs

This is a Notice of Special Interest (NOSI) from NCI (NOT-CA-24-016). Applications must be submitted under one of the specified parent R21 NOFOs and follow all SF424 (R&R) and NOFO instructions. Key conditions: 1) Submit under PA-20-195 (NIH Parent R21, Clinical Trial Not Allowed) or PA-20-1…

Dates

Opportunity Released: December 5, 2023

Supporting links

National Institutes of Health

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers